Literature DB >> 18087147

Serum albumin, body weight and inflammatory parameters in chronic hemodialysis patients: a three-year longitudinal study.

Maurizio Bossola1, Giuseppe La Torre, Stefania Giungi, Luigi Tazza, Carlo Vulpio, Giovanna Luciani.   

Abstract

BACKGROUNDS AND AIMS: The present study aimed at making prospective longitudinal measurements of nutritional and inflammatory parameters to determine whether nutritional and inflammatory status decline or increase over time in a cohort of prevalent hemodialysis patients, and to evaluate which factors influence eventual changes. PATIENTS: 64 hemodialysis patients were followed at 0, 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, and 36 months. At each follow-up visit, dry body weight, serum albumin, serum total cholesterol, total white blood cells, total lymphocyte count, serum glucose, C-reactive protein, ferritin, fibrinogen, hemoglobin, and weekly erythropoietin dose were assessed. MAIN OUTCOME MEASURES: Changes in nutritional and inflammatory parameters over time.
RESULTS: 43 patients completed the study at 36 months. Mean serum albumin levels (g/dl) improved significantly between baseline (3.76 +/- 0.24) and 36 months (3.93 +/- 0.27) (F = 4.005; p = 0.0009). Dialytic age was significantly associated with changes of serum albumin (F = 2.797; p = 0.028). The mean dry weight slightly remained stable over time (F = 1.473; p = 1.0) as well as the level of total cholesterol (p = 0.77) and lymphocyte count (F = 1.539; p = 0.186). Over time, the levels of C-reactive protein tended to decrease, although the differences were not statistically significant (F = 1.332; p = 0.19). Over time, the serum level of fibrinogen (F = 0.422; p = 0.17) and ferritin (F = 0.314; p = 0.52) remained stable. The number of white blood cells significantly decreased over time (F = 4.691; p = 0.0079) and dialytic age (F = 3.214; p = 0.015) was the variable significantly associated with such decline. The hemoglobin levels (F = 1.423; p = 0.14) and the weekly erythropoietin dose did not change significantly during the study (F = 1.019; p = 0.61), nor did the serum glucose levels (F = 1.231; p = 0.10).
CONCLUSION: These results support the hypothesis that end-stage renal disease and HD are not necessarily associated with deterioration of the nutritional status over time. Copyright (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18087147     DOI: 10.1159/000112597

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  5 in total

1.  The predictive value of malnutrition for functional and cognitive status in elderly hemodialysis patients.

Authors:  Irina Mihaela Abdulan; Mihai Onofriescu; Ramona Stefaniu; Alexandra Mastaleru; Veronica Mocanu; Ioana-Dana Alexa; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2018-12-04       Impact factor: 2.370

2.  Serum albumin as predictor of nutritional status in patients with ESRD.

Authors:  Thiane Gama-Axelsson; Olof Heimbürger; Peter Stenvinkel; Peter Bárány; Bengt Lindholm; Abdul Rashid Qureshi
Journal:  Clin J Am Soc Nephrol       Date:  2012-06-21       Impact factor: 8.237

3.  Clinical predictors of decline in nutritional parameters over time in ESRD.

Authors:  Claire H den Hoedt; Michiel L Bots; Muriel P C Grooteman; Neelke C van der Weerd; E Lars Penne; Albert H A Mazairac; Renée Levesque; Peter J Blankestijn; Menso J Nubé; Piet M ter Wee; Marinus A van den Dorpel
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 8.237

4.  IL-6 levels, nutritional status, and mortality in prevalent hemodialysis patients.

Authors:  Ilia Beberashvili; Inna Sinuani; Ada Azar; Hila Yasur; Gregory Shapiro; Leonid Feldman; Zhan Averbukh; Joshua Weissgarten
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-18       Impact factor: 8.237

5.  Longitudinal study of leptin levels in chronic hemodialysis patients.

Authors:  Ilia Beberashvili; Inna Sinuani; Ada Azar; Hila Yasur; Leonid Feldman; Zhan Averbukh; Joshua Weissgarten
Journal:  Nutr J       Date:  2011-06-15       Impact factor: 3.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.